What are the non-benzodiazepine Z-drugs and how do they differ from benzodiazepines?

• A. Z-drugs—zolpidem, zaleplon, eszopiclone; selective GABA-A activity with less anxiolytic/muscle relaxant effects; still carry dependence risk.
• B. Z-drugs—trazodone, mirtazapine, doxepin; selective serotonin reuptake inhibitors; no dependence risk.
• C. Z-drugs—temazepam, flurazepam, quazepam; long-acting benzodiazepines; high abuse potential.
• D. Z-drugs—melatonin, ramelteon, agomelatine; melatonin receptor agonists; not sedative.

Answer: (A)

Z-drugs—zolpidem, zaleplon, and eszopiclone—are non-benzodiazepine sleep medications that still act on the GABA-A receptor, boosting the inhibitory effects of GABA to promote sleep. What sets them apart from benzodiazepines is their greater selectivity for the alpha-1 subunit of GABA-A, which mainly mediates hypnotic effects. That means they produce sleep with fewer daytime effects like anxiolysis or muscle relaxation.

Because of this targeted action, Z-drugs often have a shorter duration of action and can cause less disruption of sleep architecture, but they do not eliminate risks. Dependence and withdrawal can still occur, and some people may experience next-day sedation, dizziness, or sleep-related behaviors such as sleepwalking.

In contrast, benzodiazepines (like temazepam or diazepam) act more broadly on GABA-A receptors, delivering a wider range of effects—anxiolysis, anticonvulsant effects, muscle relaxation—along with longer half-lives in many cases, which can increase daytime sedation and the potential for dependence.